Donley Matthew Maxwell

CIK 00016366422 companiesEDMONTON, A0

SEC Profile

Transactions

Companies

Filings

CIK

0001636642

Recent Transactions

38 trades

Tax Payment
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2026-01-02$15.95/sh−42,787→ 695,801 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2026-01-02+54,166→ 734,631 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2025-03-04$7.92/sh−58,991→ 680,465 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2025-03-03+135,567→ 805,358 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2025-03-03$8.00/sh−65,902→ 739,456 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Employee Stock Option (right to buy)
2025-02-28+126,416→ 126,416 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2025-02-28+82,781→ 669,791 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2024-03-06$5.51/sh−40,665→ 584,072 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2024-02-20+216,666→ 624,737 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2023-03-02+271,134→ 403,141 total
Purchase
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2022-11-21$4.66/sh+10,000→ 27,927 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2022-03-02+8,500→ 19,276 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2022-03-02$12.01/sh−3,052→ 16,224 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Restricted Stock Unit
2022-03-02+104,080→ 104,080 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Stock Option (right to buy)
2022-03-02+178,063→ 178,063 total
Purchase
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-05-11$10.07/sh+9,900→ 9,900 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$6.15/sh−101,000→ 0 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2018-02-13$18.00/sh−36,975→ 36,975 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$10.60/sh−150,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$11.25/sh−25,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$3.18/sh−28,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$4.20/sh−75,000→ 0 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2017-12-31$9.10/sh+330→ 36,975 total
Tax Payment
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2017-12-28$17.98/sh−19,353→ 36,645 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2017-09-30$9.10/sh+330→ 2,998 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2017-06-30$8.93/sh+336→ 2,668 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2017-03-31$9.35/sh+321→ 2,332 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2017-03-06+101,000→ 379,000 total
Award
Sucampo Pharmaceuticals, Inc.
Common stock
2017-03-06+53,000→ 53,000 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-12-31$10.46/sh+286→ 2,011 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-09-30$9.38/sh+320→ 1,725 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-03-31$9.29/sh+323→ 1,029 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-03-31$9.32/sh+376→ 1,405 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2016-03-02+75,000→ 278,000 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2015-12-31$14.70/sh+238→ 706 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2015-09-30$14.52/sh+207→ 468 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2015-06-30$13.37/sh+261→ 261 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2015-03-04+28,000→ 203,000 total

Companies

Recent Filings

Address

#140, 14315-118 AVENUE

EDMONTON, A0, T5L 4S6

View on SEC.gov